Arthritis Foundation Announces Top 10 Arthritis Advances of 2005, Predictions for Year Ahead

Summary


ATLANTA, Jan. 10 /U.S. Newswire/ -- The recent approval of a first-in-class biologic drug for rheumatoid arthritis, the proven safety of oral contraceptives in women with lupus, and development of the first new drug for gout in 40 years are among the 10 most significant arthritis advances of 2005, according to the Arthritis Foundation.

Other big news in the past year -- the withdrawal of two popular arthritis pain medications and more stringent warnings on nonsteroidal anti-inflammatory drugs -- may have confused the public and shaken its confidence in arthritis therapies. However, new understanding of the importance of personal lifestyle choices in relieving pain and novel treatments in the pipeline provide more hope than ever in the year ahead for people of all ages suffering from the most serious and debilitating forms of arthritis and related diseases.

See the full content of this document

Extract


Arthritis Foundation Announces Top 10 Arthritis Advances of 2005, Predictions for Year Ahead

"Advances made in 2005 promise a better quality of life for patients with arthritis and related diseases in the year ahead and hint at ...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company